Febrile infants aged 22 to 60 days were less likely to be hospitalized or receive antibiotics after the AAP published updated ...

In this new “Caring for Our Kids” episode, David Wagner, Ph.D., pediatric psychologist at OHSU, discusses the Novel Interventions in Children's Healthcare (NICH) program, and how this innovative ...

In this video, Marlise R. Luskin, MD, MSCE, discusses results from a phase 3 randomized trial that investigated the addition of blinatumomab to standard chemotherapy for pediatric B-cell acute ...

In this new “Caring for Our Kids” episode, David Wagner, pediatric psychologist at Oregon Health and Science University, ...